What is the equity of Ipsen this year?
Ipsen has equity of 3.83 B EUR this year.
Ipsen Equity 2025
Ipsen Equity
3.83 B EUR
Ticker
IPN.PA
ISIN
FR0010259150
WKN
A0ESMG
In 2025, Ipsen's equity was 3.83 B EUR, a 14.39% increase from the 3.34 B EUR equity in the previous year.
Ipsen Aktienanalyse
What does Ipsen do?
Ipsen SA is a French biopharmaceutical company specialized in the development of drugs for the treatment of cancer, neurological disorders, and endocrine disorders. It was founded in 1929 by a pharmacist named Henri Beaufour and is headquartered in Paris. The history of Ipsen began with the production of extraction products from snake venom for the manufacturing of serum against tetanus and diphtheria. In the 1960s, the company started to focus on the production of hormones and peptides, with a focus on endocrine disorders. In the 1990s, Ipsen expanded its product portfolio to include oncology and neurological disorders. Ipsen's business model focuses on research and development of new drugs, as well as marketing of already established drugs in selected markets worldwide. The company employs around 5,700 employees and operates in more than 115 countries. Ipsen has two main business segments: specialty drugs and consumer healthcare. The specialty drugs segment focuses on the development and marketing of innovative therapies in the areas of oncology, endocrinology, and neuroscience. Ipsen's most well-known products include Somatuline, a drug for the treatment of acromegaly, and Decapeptyl, a drug for the treatment of prostate cancer and endometriosis. In the consumer healthcare segment, Ipsen is mainly specialized in the production of drugs for the treatment of gastrointestinal disorders and cold and flu symptoms. Some well-known brands include Smecta, a drug for diarrhea, and Nurofen, a pain reliever. Ipsen also has a strong presence in the field of aesthetic medicine, where the company operates a subsidiary called Ipsen Aesthetic. This subsidiary develops and markets products for the treatment of wrinkles and other signs of aging on the skin. Well-known brands of Ipsen Aesthetic include Dysport, a botulinum toxin product for the treatment of wrinkles, and the filler Restylane. Overall, Ipsen has established itself as a leading biopharmaceutical company focused on the development and marketing of products in specialized therapy areas. The company has a strong pipeline of new products in development and remains an important player in the pharmaceutical industry due to its strong scientific expertise and global presence. Ipsen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Ipsen's Equity
Ipsen's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ipsen's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Ipsen's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Ipsen's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Ipsen’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Ipsen stock
What was the equity of Ipsen compared to the previous year?
The equity of Ipsen has increased/decreased by 14.39% increased compared to the previous year.
What impact does a high equity have on investors of Ipsen?
A high equity is advantageous for investors of Ipsen as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Ipsen?
A low equity can be a risk for investors of Ipsen, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Ipsen affect the company?
An increase in equity of Ipsen can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Ipsen affect the company?
A reduction in equity of Ipsen can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Ipsen?
Some factors that can affect the equity of Ipsen include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Ipsen so important for investors?
The equity of Ipsen is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Ipsen take to change the equity?
To change equity, Ipsen can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Ipsen pay?
Over the past 12 months, Ipsen paid a dividend of 1.2 EUR . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Ipsen is expected to pay a dividend of 1.4 EUR.
What is the dividend yield of Ipsen?
The current dividend yield of Ipsen is 1.01 %.
When does Ipsen pay dividends?
Ipsen pays a quarterly dividend. This is distributed in the months of June, June, July, June.
How secure is the dividend of Ipsen?
Ipsen paid dividends every year for the past 24 years.
What is the dividend of Ipsen?
For the upcoming 12 months, dividends amounting to 1.4 EUR are expected. This corresponds to a dividend yield of 1.18 %.
In which sector is Ipsen located?
Ipsen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ipsen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ipsen from 6/3/2024 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.
When did Ipsen pay the last dividend?
The last dividend was paid out on 6/3/2024.
What was the dividend of Ipsen in the year 2024?
In the year 2024, Ipsen distributed 1.2 EUR as dividends.
In which currency does Ipsen pay out the dividend?
The dividends of Ipsen are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ipsen stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ipsen
Our stock analysis for Ipsen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ipsen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
